Can population differences in chemotherapy outcomes be inferred from differences in pharmacogenetic frequencies

QR Code

Can population differences in chemotherapy outcomes be inferred from differences in pharmacogenetic frequencies

Inter-ethnic differences in drug handling and frequencies of pharmacogenetic variants are increasingly being characterized. In this study, we systematically assessed the feasibility of inferring ethnic trends in chemotherapy outcomes from inter-ethnic differences in pharmacogenetic variant frequenci...

Full description

Bibliographic Details
Main Authors:	Loh, M., Chua, D., Yao, Y., Soo, R., Garrett, K., Zeps, Nikolajs, Platell, C., Minamoto, T., Kawakami, K., Iacopetta, B., Soong, R.
Format:	Journal Article
Published:	2013
Online Access:	http://hdl.handle.net/20.500.11937/21055

Similar Items

Prognostic significance of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase protein expression in colorectal cancer patients treated with or without 5-fluorouracil-based chemotherapy
by: Soong, R., et al.
Published: (2008)

Pipeline pharmacogenetics: A novel approach to integrating pharmacogenetics into drug development
by: Akkari, Patrick, et al.
Published: (2009)

Pharmacogenetics, pharmacogenomics and airway disease
by: Hall, Ian P.
Published: (2002)

Pharmacogenetics in cardiovascular disorders: An update on the principal drugs
by: Predazzi, I., et al.
Published: (2013)

Pharmacogenetics of beta adrenergic blockers: their clinical significance
by: Elsayed, Tarek Mohamed Ali
Published: (2009)

Phenotypic and pharmacogenetic evaluation of patients with thiazide-induced hyponatremia
by: Ware, James S., et al.
Published: (2017)

Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer
by: Salama, P., et al.
Published: (2009)

Benchmarking in silico tools for the functional assessment of DNA variants using a set of strictly pharmacogenetic variants
by: Chua, Eng Wee, et al.
Published: (2019)

Utility of pharmacogenetic testing to optimise antidepressant pharmacotherapy in youth: a narrative literature review
by: Roberts, B., et al.
Published: (2023)

The Personalization of Clopidogrel Antiplatelet Therapy: The Role of Integrative Pharmacogenetics and Pharmacometabolomics
by: Amin, Arwa M., et al.
Published: (2017)

Patients with colorectal tumors with microsatellite instability and large deletions in HSP110 T17 have improved response to 5-fluorouracil-based chemotherapy
by: Collura, A., et al.
Published: (2014)

Metabolomics and pharmacogenetics based 5-fluorouracil monitoring in colorectal cancer patients
by: Zakaria, Bannur, et al.
Published: (2014)

Metabolomics and pharmacogenetics based 5-fluorouracil monitoring in colorectal cancer patients
by: Bannur, Zakaria, et al.
Published: (2014)

The role of pharmacogenetic variation in metoprolol CYP2D6 genotypes polymorphism
by: Wan Sulaiman, Wan Mohd. Azizi, et al.
Published: (2011)

The expression of RUNX3 in colorectal cancer is associated with disease stage and patient outcome
by: Soong, R., et al.
Published: (2009)

Can body composition be used to optimize the dose of platinum chemotherapy in lung cancer? A feasibility study
by: Crosby, Vincent, et al.
Published: (2016)

A Clinical And Pharmacogenetic Investigation Of Methadone Maintenance Therapy (MMT) In Opiate Dependent Individuals
by: Mohamad, Nasir
Published: (2011)

Can time difference deter arbitrage opportunities?
by: Bogomolov, T., et al.
Published: (2013)

We can make a difference to Earth
by: Abd Razak, Dzulkifli
Published: (2009)

Tumour banking as part of routine clinical practice
by: Platell, C., et al.
Published: (2010)

A pharmacogenetics study on acute pain perception among patents on methadone maintenance therapy (MMT)
by: Zahari, Zalina
Published: (2016)

PEGylation of paclitaxel for inhaled chemotherapy
by: Luo, Tian
Published: (2016)

Rare Cancers
by: Zeps, Nikolajs, et al.
Published: (2015)

Managing the ethical issues of genomic research using pathology specimens
by: Zeps, Nikolajs, et al.
Published: (2015)

Molecular responses during chemotherapy in acute myeloid leukemias in predicting poor-response to standard chemotherapy.
by: Abdullah, Maha, et al.
Published: (2009)

Knowledge, perception and confidence of physicians and pharmacists at IIUM Medical Centre towards pharmacogenetics application in clinical setting
by: Azmi, Diyana, et al.
Published: (2019)

Overcoming resistance of targeted EGFR monotherapy by inhibition of STAT3 escape pathway in soft tissue sarcoma
by: Wang, X., et al.
Published: (2016)

Identification and phylogenetic inference in different mollucs nudibranch species via mitochondrial 16S rDNA
by: Alqudah, Ali, et al.
Published: (2015)

Early intervention can make a difference in Alzheimer's prevention
by: Roslan, Muhammad Basir
Published: (2021)

The Reciprocal Interaction: Chemotherapy and Tumor Microenvironment
by: Kim, S., et al.
Published: (2011)

SPARC, FOXP3, CD8 and CD45 correlation with disease recurrence and long-term disease-free survival in colorectal cancer
by: Chew, A., et al.
Published: (2011)

Neoadjuvant chemoradiotherapy for rectal cancer: how important is tumour regression?
by: McCoy, M., et al.
Published: (2015)

How accurately can other people infer your thoughts -- and does culture matter?
by: Valanides, Constantinos, et al.
Published: (2017)

The Personalization of Clopidogrel Antiplatelet Therapy in Coronary Artery Disease Patients using Pharmacometabonomics, Pharmacogenetics and Platelets Function Testing
by: Mostafa, Arwa Mohamed Amin
Published: (2016)

Imatinab mesylate treatment in Chronic Myeloid Leukemia (CML)- understanding the fundamental pharmacokinetic and pharmacogenetic mechanisms for variation in response
by: Ankathil, Ravindran
Published: (2016)

Trade in human tissue products
by: Tonti-Filippini, N., et al.
Published: (2011)

Low stromal Foxp3+ regulatory T-cell density is associated with complete response to neoadjuvant chemoradiotherapy in rectal cancer
by: McCoy, M., et al.
Published: (2015)

Dysphagia, Speech, Voice, and Trismus following Radiotherapy and/or Chemotherapy in Patients with Head and Neck Carcinoma: Review of the Literature
by: Heijnen, B., et al.
Published: (2016)

Cost of cancer care for patients undergoing chemotherapy: The Elements of Cancer Care study
by: Ward, R., et al.
Published: (2015)

Variability in responses of tacrolimus in kidney transplant patients: the use of pharmacogenetics and metabolomics in closing the gaps in clinical practices / Sharina Hamzah
by: Hamzah, Sharina
Published: (2013)